Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
The newest reason for doing everything possible to reduce childhood obesity names certain cancers as risks associated with a high BMI….
Read More »The Effects of GLP-1 on Cardiovascular Health
Tina Burge, Doctor of Pharmacy Candidate, FAMU College of Pharmacy Reviewed by Dave Joffe, BSPharm, CDE It’s well-known that patients with diabetes have an increased risk of cardiovascular disease when compared to patients without diabetes. Diabetes type 2 has a high prevalence in the obese (BMI ³ 25kg/m2) and overweight …
Read More »Waist Size Determines Cardio-Metabolic Risk in Diabetes
A bigger waistline, coinciding with a higher risk of cardio-metabolic complications in type 2 diabetes patients, suggests that waist measurement is critical for this population….
Read More »Diabetes Remission after Gastric Bypass Determined by Beta Cell Function Not Weight Loss
Remission of type 2 diabetes in severely obese people after bariatric surgery hinges on baseline beta cell function, not weight loss….
Read More »Race, Diabetes Influence Weight Loss after Gastric Bypass
Black women experienced less weight loss than white women after gastric bypass surgery….
Read More »Silva A. Arslanian, MD, Q4: Disparities in diabetes rates between children of different socio-economic class
Dr. Arslanian confirms that she is seeing a higher incidence of type 2 diabetes in children in lower socio-economic classes, where there is also a higher obesity rate. More videos with Dr. Arslanian: Silva A. Arslanian, MD, Introduction T2DM in Children – Earlier co-morbidities? What drugs can be prescribed to …
Read More »Silva A. Arslanian, MD: How does the drug approval process differ for children?
Silva A. Arslanian, MD, explains the rigorous process for gaining approval for new diabetes drugs for children, and points out that the type 2 rate is not yet at epidemic proportions in children (as it is in adults)….
Read More »Silva A. Arslanian, MD: What drugs can be prescribed to children with diabetes?
With all of the discussion in the medical community and beyond regarding new drug approvals for diabetes, it is easy to forget that many of these drugs are not approved for children and adolescents. Silva A. Arslanian, MD, Professor of Pediatrics, University of Pittsburgh School of Medicine, explains why this is and describes …
Read More »Silva A. Arslanian, MD, Q1: T2DM in Children – Earlier co-morbidities?
Dr. Arslanian talks about the earlier incidence rate of ESRD of people who have type 2 in childhood as well as her own team’s studies on cardiovascular markers, and the premature “aging” of the CV system seen in these individuals. She also discusses the challenges of children growing up in …
Read More »Oded Langer, MD, PhD, Q3: What Is the Best Test for Blood Glucose Levels in Diabetic Women?
Dr. Langer explains why HbA1c is not a good a test for pregnant women because of the natural changes in a pregnant woman’s blood cells as well as the limited time of the pregnancy (as compared to measuring HbA1c over longer periods of time in a non-pregnant person). He discusses …
Read More »